YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk ends pact with Hims & Hers

Posted online

Novo Nordisk is ending a collaboration with Hims & Hers after announcing in April that it would offer weight loss drug Wegovy through several such telehealth companies.

Officials with Novo Nordisk allege Hims & Hers has “failed to adhere to the law which prohibits mass sales of compounded drugs” under the “false guise” of personalization, CNBC reports.

Novo Nordisk also accused Hims & Hers of engaging in "deceptive" marketing.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences